Jian Li

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityNanomaterialsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 03, 2026
Non-canonical role of Ku80 stabilizes Rab7A to enhance mitolysosome formation and chemotherapy in liver cancer.

|Apr 22, 2026
High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients.

|Nov 27, 2024
Higher Expression of Ku80 and Ku70 Indicates Hotter Tumor Immune Microenvironment in Hepatocellular Carcinoma and Better CTL-Centered Immunotherapy.

Lukun Yang, Ling Li, Peiping Li

|Nov 03, 2022
Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway.

Junlu Tong, Li Cong, Yingbin Jia

|Sep 09, 2022
Hsa-microRNA-370-3p targeting Snail and Twist1 suppresses IL-8/STAT3-driven hepatocellular carcinoma metastasis.

Siqi Peng, Yutong Chen, Ting Li

Pageof 1

Frequent Collaborators

3 joint publications

Baojia Zou

1 joint publications

Linjuan Zeng

1 joint publications

Junlu Tong

1 joint publications

Yifan Guo